All News #Library
Biotech
Amylyx Completes Ph3 LUCIDITY Trial Enrollment
24 Mar 2026 //
BUSINESSWIRE
Amylyx Pharma Reveals AMX0114 Safety Data In ALS Trial
05 Dec 2025 //
BUSINESSWIRE
Amylyx Shares Avexitide Bariatric Data at ENDO 2025
13 Jul 2025 //
BUSINESSWIRE
Amylyx to Present Avexitide Data at ENDO 2025
08 Jul 2025 //
BUSINESSWIRE
Amylyx Pharmaceuticals Starts Phase 1 Trial of AMX0114 in ALS
09 Apr 2025 //
BUSINESSWIRE
Amylyx Unveils Phase 3 LUCIDITY Trial For Avexitide In Hypoglycemia
04 Dec 2024 //
BUSINESSWIRE
ALS biotech QurAlis gets $88M boost from four pharmas for pair of PhI studies
09 Mar 2023 //
ENDPTS

Market Place
Sourcing Support